Associations between frequent pain or headaches and neurobehavioral symptoms by gender and TBI severity.
Karen J MeltzerShannon B JuengstPublished in: Brain injury (2021)
Objective: To investigate differences in frequent pain or headaches and associated neurobehavioral symptoms among men, women, and transgender individuals with and without a history of traumatic brain injury (TBI).Setting: CommunityParticipants: English and Spanish-speaking adults (n = 2,862) with and without self-reported TBIDesign: Cross-sectional studyMain Measures: Behavioral Assessment Screening Tool (BAST) subscales for Negative Affect, Substance Abuse, Executive Function, Fatigue, Impulsivity, and one item for experiencing "frequent pain or headache."Results: Women reported more pain than men. Women with a mild TBI (mTBI) more often reported frequent headaches/pain than woman in general or those with mTBI alone. Women reporting frequent headache/pain reported more negative affect and fatigue than men with comparable TBI history. Individuals identifying as transgender/other without TBI had higher negative affect and fatigue than both men and women without TBI. Individuals with mTBI and frequent headache/pain reported more executive function problems than those with mTBI without headache/pain. Pain and moderate/severe TBI were associated with more executive function problems in men and women, but more so for women.Conclusion: Results suggest frequent headache/pain may differ between genders, particularly after mTBI. Pain, fatigue, executive function, and negative affect may be especially important in women's recovery from TBI.
Keyphrases
- traumatic brain injury
- chronic pain
- pain management
- neuropathic pain
- mild traumatic brain injury
- mental health
- type diabetes
- emergency department
- sleep quality
- pregnant women
- metabolic syndrome
- adipose tissue
- depressive symptoms
- early onset
- physical activity
- deep brain stimulation
- obsessive compulsive disorder
- case report
- middle aged
- electronic health record
- clinical evaluation
- adverse drug